At some point we need to have a talk about the "no editorialized titles" rule, because while I agree that there's a risk of having the submitter inject their ow

At some point we need to have a talk about the "no editorialized titles" rule, because while I agree that there's a risk of having the submitter inject their own bias, a title of "Sarepta. Why?" is totally beyond useless for a news aggregator website that isn't exclusively tailored for pharma. I propose two fields when submitting a link: the original title, and an optional "additional context" field.